"*"You can\'t improve what you can\'t measure."* ---Anonymous"

Inpatient hyperglycemia is a very common condition, affecting 32-38% of patients in the non-intensive care unit (non-ICU) setting. Observational and randomized, controlled studies suggest that improved glycemic control results in lower rates of hospital complications in general medical and surgical patients.^[@B1]^ Hypoglycemic adverse drug events are also common in the hospital setting, and approximately half of these events are preventable.^[@B1],[@B2]^ Hypoglycemia management is often delayed and ineffective in preventing recurrent hypoglycemia.^[@B3]-[@B5]^ The Society of Hospital Medicine (SHM) has joined other organizations in stressing the importance of improving glycemic control while paying proper attention to hypoglycemia prevention and management.^[@B1],[@B2],[@B6]-[@B9]^ Although all hospitals address these issues to some extent, many attempt to implement a variety of interventions and resources with minimal capacity to assess the positive (or unintentionally negative) consequences of their investment.^[@B1],[@B9]^

Difficulties in measuring, analyzing, tracking, and benchmarking the quality of inpatient glycemic control were identified as rate-limiting steps in the improvement process as SHM engaged hospitals in collaborative improvement efforts.^[@B1],[@B8]-[@B13]^ Subsequently, SHM partnered with a data management company (QuesGen Systems, Burlingame, Calif.) to develop a Web-based data and reporting center for a wide range of measures using glucose values (also called "glucometrics")^[@B14]^ that would allow hospitals to assess their baseline performance, track their progress over time, and compare performance across similar units within their institution. In addition to these measures and internal benchmarking capacity, SHM also created external benchmarking reports, allowing for comparisons of performance across different institutions in the database.

SHM Glucometrics {#s1}
================

Hospitals enrolled in the SHM Glycemic Control Mentored Implementation programs, or that subscribe to an electronic quality improvement program in glycemic control, upload blood glucose data in a secure and de-identified process. Only point-of-care (POC) blood glucose values are uploaded to prevent duplicate "mirror" serum and blood glucose values and to maximize ease of uploading data for participating hospitals. The blood glucose values, with their date, time, patient unit, and an encrypted numeric patient encounter identifier, are uploaded in a standardized format. Data from multiple months and units can be uploaded in a single session. Patient demographics, medications, sex, and other data fields are excluded. Patients with fewer than four blood glucose readings or with only one hospital day are excluded, and data are "scrubbed" for erroneous or questionable values.

Metrics summarizing rates of hyperglycemia, hypoglycemia, recurrent hypoglycemia, and the timeliness of hypoglycemia management and resolution were devised by SHM glycemia experts. SHM glucometrics use the patient-day as the preferred unit of analysis, a common practice with the advantage of providing a uniform unit of time, adjusting to some degree for repeated testing around glycemic excursions and other local variations in testing patterns.^[@B13]-[@B18]^ The degree of glycemic control can be summarized as a day-weighted mean for a chosen group of patients (i.e., the mean of all readings for one patient-day, then averaged across all patient-days in that group), the percentage of patient-days with a mean (day-weighted) ≥ 180 mg/dl, the percentage of patient-days with all readings 70-179 mg/dl, or the percentage of patient-days with any blood glucose reading \> 299 mg/dl. In a similar manner, hypoglycemia is summarized as the percentage of patient-days with at least one blood glucose reading \< 70 mg/dl and severe hypoglycemia as the percentage of patient-days with any glucose reading \< 40 mg/dl. Selected metrics are also expressed with the patient-stay as the unit of analysis, with a patient-stay being defined as consecutive days for which blood glucose readings are available for a patient (e.g., the percentage of patients with at least one hypoglycemic event during their stay, the percentage of hypoglycemic patients with recurrent hypoglycemic days during their stay, and the percentage of patients with a day-weighted mean ≥ 180 mg/dl over the course of their stay). The mean for a patient-stay is also based on a day-weighted methodology (mean glucose for day 1 + mean glucose for day 2 + mean glucose for day 3 / 3 days = a patient\'s mean glucose for a 3-day hospitalization) in a minor modification of Yale methodology.

Internal Measures and Benchmarking {#s2}
==================================

After the data are uploaded, authorized users can run reports for their own institution on demand, rather than wait for fixed reports. Webinar demonstrations are available on the SHM website.^[@B19]^ Four types of reports are available from pull-down menus: a Tabular Summary Overview, Patient-Day reports, Patient-Stay reports, and a unique Hypoglycemia Management report, which tracks recurrent hypoglycemia and time intervals to repeat testing and resolution after the index event. All but the Tabular Summary Overview depict month-to-month results, as well as a summary row that provides the results for the entire time period. Menus allow for flexibility in report construction. For example, reports can be run for a single month or for all months in the database, and the performance for non-ICUs (or for ICUs) can be viewed as a composite, either separately for individual units or with any grouping of similar units. This variety of reports allows for establishing baseline performance, tracking trends over time, and establishing local benchmarking for similar units.

Establishing baseline performance {#s3}
=================================

"*"You can\'t know where you are going until you know where you\'ve been."* ---Anonymous"

The Tabular Summary Overview report establishes the baseline level of inpatient glycemic control being achieved on any or all units. The baselines for hypoglycemia and hypoglycemia management are also available. The baseline report can raise awareness and support for glycemic control issues when presented to leadership and staff. For example:"In the past six months, we followed 1,774 patients over 7,156 days on our non-ICU units. Six hundred patients (more than one-third) had a mean glucose of ≧ 180 mg/dl during their stay. More than 5% of monitored-days and 90 patient-stays (15%) had at least one hypoglycemic event, with 30% of hypoglycemic patients suffering from at least one recurrence. The mean time to document resolution of a hypoglycemic event was 90 minutes, even though our protocol calls for repeat testing every 15 minutes."

The team at the institution in this example used the report to focus efforts on the timeliness and effective management of hypoglycemia. Nursing councils helped to simplify the hypoglycemia documentation and revised the hypoglycemia protocol to emphasize the identification and mitigation of contributors to the hypoglycemic event to prevent recurrent hypoglycemia. Educational programs with demonstration of nursing competency were initiated, and each unit received monthly feedback on progress until substantial improvement was achieved.

Assessing the impact of interventions: tracking trends over time {#s4}
================================================================

After baseline performance is established, it is possible to objectively assess the impact of interventions on baseline performance over time. As improvement teams educate staff and introduce interventions, increased awareness often leads to surveillance bias, with subsequent increases in voluntary reporting and anecdotes of hypoglycemic events. The availability of high-quality, objective data on hypoglycemia rates is a much better basis on which to make decisions about the safety of glycemic control interventions and can be reassuring to all concerned. The SHM reports offer run charts to complement tabular displays of month-to-month data because they are more accessible and intuitive to many audiences. [Figure 1](#F1){ref-type="fig"} is a run chart from the Patient-Day report, depicting a reduction in hypoglycemia over time.

![Hypoglycemia run chart for non-ICU units. Run chart depicting the percentage of patient-days for the selected patient units with any hypoglycemic value (blood glucose \< 70 mg/dl, in green) and any severe hypoglycemic value (blood glucose \< 40 mg/dl, in gold) by month. Other run charts are available depicting changes over time for a variety of metrics.](212fig1){#F1}

Internal benchmarking {#s5}
=====================

Individual units within a given institution may vary significantly in their prioritization of insulin management principles, training, and processes related to glycemic control. The SHM reporting system can identify this variation by allowing for comparison of performance among similar units at a given institution. This internal benchmarking identifies top performers, encourages a healthy competition for better performance, and can lead to identification of best practices and improved buy-in for shared glycemic goals. Reports that depict unit-specific performance often resonate with staff more than institution-wide reports and can lead to better staff accountability for hypoglycemia management and other parameters.

External Benchmarking {#s6}
=====================

"*"If you don\'t know where you are going, you will wind up somewhere else."* ---Yogi Berra"

External benchmarking services were repeatedly requested by hospitals involved in SHM\'s glycemic control improvement offerings because improvement teams wanted realistic goals and perspective on their performance. In 2013, SHM released its first round of external benchmarking reports to participating hospitals. "Non-core" areas such as dialysis units, recovery rooms, psychiatric wards, and emergency departments were excluded. All core units for each hospital were combined to establish the composite performance for the entire hospital, subdivided by ICU and non-ICU units. Each of the 76 hospitals received benchmarking reports depicting the performance for the past 6 months of uploaded data of every hospital, with a numeric code allowing them to identify their own hospital (but not other hospitals).

A tabular report similar to [Table 1](#T1){ref-type="table"} allowed them to compare their own performance to the mean, median, and top-quartile performance levels of the 76 hospitals contributing non-ICU data. The wide range of performance is typical for hospitals with varied sophistication and standardization, as well as varied patient populations. The top quartile should be viewed as an "achievable benchmark," rather than the ultimate goal because a full 25% of hospitals were able to achieve these levels across all of their non-ICU units on average.

###### 

Benchmarking for Selected Glucometrics From 76 Hospitals: Core Non-ICU Adult Units\*

![](212tbl1)

Hospital performance is ranked for several important metrics, and a rank order bar chart plots absolute performance on the y-axis and consecutive relative performance on the x-axis. [Figure 2](#F2){ref-type="fig"} provides an example of the report for the percentage of patient-days \> 299 mg/dl. Each hospital can distinguish itself from others in the cohort by entering the hospital numeric identifier in the benchmarking report, which highlights its ranking in red.

![Rank-order bar chart of percentage of patient-days with blood glucose results \> 299 mg/dl for non-ICU units. Hospitals are assigned a rank order for performance, in this case for the percentage of patient-days with severe hyperglycemia. Each hospital is depicted by a vertical bar, with lower rank depicting better performance from left to right on the x-axis, and the absolute performance on the y-axis. The green horizontal line designates median performance for the cohort. The red color helps each hospital identify its own site at a glance.](212fig2){#F2}

[Figure 3](#F3){ref-type="fig"} is an example of an SHM benchmarking scatterplot. As in the rank order bar chart plots, each hospital can identify its own institution by entering its numeric coded hospital identifier, which highlights its institution in red. Each hospital\'s performance on a glycemic control parameter is depicted on the y-axis (in this case, the day-weighted mean blood glucose for non-ICU patients), while a hypoglycemia parameter (percentage of patient-days \< 70 mg/dl) is depicted on the x-axis. Lower, median, and upper quartile boundaries are clearly marked.

![Benchmarking scatterplot for non-ICU units. Each hospital is depicted by its number and its position, defined by its performance for glycemic control (day-weighted mean glucose) on the y-axis, and hypoglycemia rates per patient-day on the x-axis. Quartiles of performance are depicted by the broken lines, with the top performers in the left lower quadrant attaining the best quartile of performance for both hyper- and hypoglycemia rates. The red color highlights an individual hospital\'s performance. BG, blood glucose.](212fig3){#F3}

This juxtaposition of hyper- and hypoglycemic performance on one graph makes the trade-offs and priorities for each institution more apparent. For example, in [Figure 3](#F3){ref-type="fig"}, the highlighted hospital might be falsely reassured by looking solely at the glycemic control metric because it is in the top quartile with a day-weighted mean blood glucose of 148 mg/dl. However, its high rate of hypoglycemia (6.9% of patient-days) places it in the bottom quartile of hospital performance for this parameter. In this case, prioritizing hypoglycemia prevention would be paramount, perhaps leading to less stringent glycemic targets until this pressing safety issue is addressed. Note that good glycemic control and low hypoglycemia rates are not necessarily mutually exclusive, with some hospitals achieving top quartile performance on both at the same time, and many more achieving results better than the median for both.

External benchmarking can provide validation for interventions in areas in which the institution is doing well, reassure staff about the safety of glycemic control, motivate change in a prioritized and data-driven manner, and spur further local investigation, in addition to providing goals for improvement. External benchmarking results combined with internal benchmarking can be particularly effective in communicating with leadership and staff. For example:"We recently received the benchmarking results from SHM, comparing our hospital\'s performance to that of 75 hospitals around the country. The good news is that we have lower rates of uncontrolled hyperglycemia than the median. Our hypoglycemia rates are still higher than average, even though we know from tracking data over the past year that we have been improving. The benchmarking study suggests that we can improve hypoglycemia a lot more by focusing on reduction of recurrent hypoglycemic events, where we are ranked 68 out of 76."

Discussion and Conclusion {#s7}
=========================

Many hospitals trying to improve glycemic control find themselves without the capacity to gauge their performance or track changes over time. Hospitals building their own glucometrics may find it labor intensive and distracting from other improvement areas, and such efforts may still leave them without external benchmarking. In this article, we illustrate how SHM internal and external benchmarking tools can be used to improve inpatient control. Achievable benchmarks for a wide variety of glucometrics were established, while also revealing variability of performance across hospitals and opportunities for improvement. Presenting results in scatterplots reinforces the importance of weighing hyper- and hypoglycemic parameters together when assessing performance and setting priorities.

There are limitations to these tools. The hospitals enrolled are self-selected. Although we have attempted to streamline the data uploading process, it still requires effort on the part of each hospital. The repository of glucometrics data has to be accessed locally and converted to the comma-separated value (.csv) format, and each unit needs to be assigned descriptive labels defining care type (Critical Care, Non-Critical Care, or Other) and unit type (e.g., Medical, Surgical, Mixed, or Obstetrics/Gynecology). Once in a .csv format, the first upload generally takes no longer than 1-2 hours. Subsequently, the system recognizes the unit labels and classifies them automatically, and uploading subsequent months of data can generally be performed in 10-30 minutes. Participating sites do not need to do any additional work to receive external benchmarking reports, but they do need to gain some familiarity with the on-demand reporting engine to leverage it to maximal advantage. A few sites are unable to surmount the barrier of uploading data because of local concerns about confidentiality despite reassurances about how the data are protected and de-identified.

Only POC blood glucose data are used, despite potential accuracy issues, especially in the ICU setting. We made this decision because of the ubiquitous nature of POC blood glucose testing, the difficulty many hospitals would have uploading a combination of serum and POC blood glucose values, a desire to avoid duplicate blood glucose readings, and previous studies showing minimal impact on glycemic control parameters with exclusion of serum blood glucose readings.^[@B14]^

Although our measures are quite similar to others in use, there is currently no consensus on measurement methods.^[@B1],[@B9],[@B13]-[@B18]^ We do not have access to medications, comorbidities, diagnostic codes, or demographics and thus cannot adjust for these factors. Use of the patient-day as the unit of measurement controls for some variation in testing patterns but does not entirely control for varied patterns of blood glucose testing. The SHM measurement tools do not fulfill the need to monitor insulin management patterns and order set utilization or to proactively identify and mitigate management issues with glycemic outliers. Improvement teams still need to address these needs locally.

On the other hand, the SHM benchmarking tools offer some advantages. Others offer tools for external benchmarking^[@B17],[@B18]^ or internal reporting and benchmarking,^[@B14]-[@B16]^ but to our knowledge, SHM is the only source that offers the combination of internal and external benchmarking resources. The SHM tools also offer several unique features (e.g., run charts, flexible on-demand reporting, and metrics for recurrent hypoglycemia and the timeliness of hypoglycemia management). Customization of the reports down to the unit level is possible for internal benchmarking and tracking. Finally, the SHM glucometrics reporting engine is surrounded by other resources (e.g., an active online community, webinars, slide decks, and print materials) to assist improvement teams in addressing the full range of inpatient glycemic control issues. Future efforts will objectively evaluate the effectiveness of this combination of tools in improving hypo- and hyperglycemia.
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